内镜手工缝合在胃ESD后可行、安全并可降低出血风险:多中心初步研究
这项多中心前瞻性初步研究纳入30例胃ESD患者,ESD后立即行内镜手工缝合(EHS)闭合黏膜缺损。29例(97%)完成缝合,25例(84%)在术后第3天闭合维持良好;3例(10%)因严重术后出血需急诊内镜。持续闭合的24例(除外1例残胃)均无出血,无论是否服用抗血栓药。
要点
- 胃ESD后EHS缝合技术成功率高(29/30,97%)且无严重不良事件。
- 术后第3天闭合维持率84%(25/30)。
- 持续闭合者无出血,包括服用抗血栓药者(0/11和0/13)。
核心结论
- EHS在胃ESD后可行且安全,若黏膜缝合成功并持续闭合,可降低术后出血风险,包括接受抗血栓治疗的患者。
研究设计与样本
- 多中心前瞻性初步研究,在3家机构招募计划行胃ESD的患者,ESD后立即行EHS闭合黏膜缺损。
- 共分析30例患者数据,其中15例服用抗血栓药,15例未服用。
- 主要结局为术后第3天内镜评估缺损闭合是否充分持续;术后第3~4周门诊随访延迟出血。
主要发现
- EHS完成黏膜闭合29/30例(97%)。
- 术后第3天闭合维持良好25/30例(84%)。
- 3例(10%)因严重术后出血需急诊内镜,其中1例缝合不完全。
- 除外1例残胃,持续闭合的24例均无出血,服用与未服用抗血栓药者分别为0/11和0/13。
- EHS过程中无严重不良事件。
临床怎么用
- 胃ESD后可行EHS闭合黏膜缺损,以期降低术后出血风险。
- 缝合成功且持续闭合者,即使服用抗血栓药也可能减少出血。
局限性
- 初步研究样本量小(30例),需更大规模研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Endoscopic hand-suturing (EHS) provides secure intraluminal mucosal closure and should decrease the risk of adverse events after gastric endoscopic submucosal dissection (ESD). We prospectively investigated the feasibility and safety of EHS after gastric ESD, particularly for preventing post-ESD bleeding. METHODS: Patients scheduled for gastric ESD at 3 institutions were prospectively recruited. Just after ESD, the mucosal defect was closed by EHS. The primary outcome was endoscopic assessment of adequately sustained closure of the defect on postoperative day 3. Endoscopy was performed to assess maintenance of the closure for the primary outcome. During postoperative weeks 3 to 4, patients were interviewed as outpatients about any occurrence of delayed bleeding. RESULTS: Data from 30 patients (15 each who did or did not take antithrombotic agents) were analyzed. Mucosal closure by EHS was completed in 29 of 30 cases (97%) and was well maintained on postoperative day 3 in 25 cases (84%). Emergency endoscopy was required for major postoperative bleeding in 3 cases (10%), including 1 in which suturing had been incomplete. Excluding 1 patient with a remnant stomach, the other 24 with sustained closure had no bleeding, regardless of whether they did or did not take antithrombotic agents (0/11 and 0/13, respectively). No serious adverse events occurred during EHS. CONCLUSIONS: Results show that EHS is feasible and safe with favorable outcomes. Provided that mucosal suturing is successfully completed and sustained, post-ESD bleeding can be decreased even in patients undergoing antithrombotic therapy. (Clinical trial registration number: UMIN 000033988.).
引用
- Goto O, Oyama T, Ono H, et al. Endoscopic hand-suturing is feasible, safe, and may reduce bleeding risk after gastric endoscopic submucosal dissection: a multicenter pilot study (with video). Gastrointest Endosc. 2020. PMID: 31923410. doi:10.1016/j.gie.2019.12.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。